Rosen Plaza Hotel Ballroom A / Livestream | Supported By: an Educational Grant from Insmed.

---

Program Description

Bronchiectasis is a progressive airway disease driven by chronic infection, neutrophilic inflammation, and recurrent exacerbations that significantly impact patients’ quality of life. While traditional management strategies remain important, many patients continue to experience disease progression, and the recent approval of the first therapy targeting neutrophil serine protease activity marks a major shift in the treatment landscape.
In this CME dinner symposium, a panel discussion among expert pulmonologists and infectious disease specialists will help clinicians translate these advances into practice. Panelists will use patient cases to highlight the role of neutrophilic inflammation in disease progression, discuss strategies for recognizing bronchiectasis earlier, and illustrate guideline-based approaches for incorporating newly approved and emerging therapies into individualized treatment plans.

Speakers

Panelist: Ashwin Basavaraj, MD, FCCP, ATSF
NYC Health + Hospitals
Pulmonary Medicine
System Chief
New York, New York

NYU Grossman School of Medicine
Bronchiectasis and NTM Education
Director
New York, New York

Panelist: Charles L. Daley, MD
National Jewish Health
Department of Medicine
Professor and Chief, Division of Mycobacterial & Respiratory Infections
Denver, Colorado

Panelist: Doreen J. Addrizzo-Harris, MD
NYU Grossman School of Medicine
Bronchiectasis and NTM Program
Director
New York, New York

NYU Grossman School of Medicine
Department of Medicine
Fiona and Stanley Druckenmiller Professor of Pulmonary, Critical Care and Sleep Medicine
New York, New York

Panelist: Shannon H. Kasperbauer, MD
National Jewish Health
Department of Medicine
Professor, Department of Medicine Division of Mycobacterial & Respiratory Infections
Denver, Colorado